# Dabigatran in Patients With Atrial Fibrillation and Mitral Biological Prostheses

> **NCT03183843** · PHASE4 · UNKNOWN · sponsor: **Research Institute for Complex Problems of Cardiovascular Diseases, Russia** · enrollment: 40 (actual)

## Conditions studied

- Mitral Valve Stenosis and Insufficiency
- Atrial Fibrillation

## Interventions

- **DRUG:** Dabigatran Etexilate
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT03183843
- **Lead sponsor:** Research Institute for Complex Problems of Cardiovascular Diseases, Russia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06-29
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-12-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183843, "Dabigatran in Patients With Atrial Fibrillation and Mitral Biological Prostheses". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03183843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*